Abstract:

Article presents the results of analysis of risk factors associated with early stent thrombosis after percutaneous coronary intervention (PCI) ir patients with acute myocardial infarction (AMI). The study is designed as an observational cohort study prospectively including 140 patients with a PCI treated AMI admitted to our hospital. Patients were divided into two groups: with and without type 2 diabetes rnellitus (DM). A number of early stent thrombosis risk factors including a complete or not complete revascularization and myocardial blush grade during PCI, based on the predictive model were analyzed. The results of the study show that DM in patients with AMI who underwent PCI was not associated with a high risk of early stent thrombosis, however, incomplete revascularization was.

References

1.     Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293: 2126-2130.

2.     McFadden E. P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519-21.

3.     Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004; 109: 701-5.

4.     Keith A.A., Philippe Gabriel Steg., Kim A. Eagle, et al. For the GRACE investigators decline in rates of death and heart failure in acute coronary syndromes. JAMA. 2007; 297: 1892-1900.

5.     Iakovou I., Schmidt T., Bonizzoni E., Ge L. et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293(17): 2126-30.

6.     Carr M. E. Diabetes mellitus: a hypercoagulable state. J. Diabetes Complications. 2001; 15: 44-54.

7.     Georgios Sianos, Marie-AngMe Morel, Arie Pieter Kappetein The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Eurolnterv. 2005; 1: 219-227.

8.     Petrosjan Ju S, Ioseliani D G. O summarnoj ocenke sostojanija koronarnogo rusla u bol'nyh ishemicheskoj bolezn'ju serdca. [Complex estimation of coronary arteries condition in patients with CAD.]. Kardiologija. 1976; 12(16): 41-46 [In Russ].

9.     Svilaas T. Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med. 2008; 358: 557.

10.   Mauri L., Hsieh W., Massaro J. M. et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 2007; 356: 1020-9.

11.   Rebrova O. Ju. Statisticheskij analiz medicinskih dannyh. [Statistic analysis of medical data]. Izd. Media Sfera. Moskva. 2003 [In Russ].

12.   Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.

13.   Norhammar A., Malmberg K., et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J. Am. Coll. Cardiol. 2004; 43(4): 585-91.

14.   Haim D. Danenberg, Greghana Marincheva, Boris Varshitzki, Hisham Nassar, Chaim Lotan Stent Thrombosis: A Poor Man's Disease? IMAJ. 2009; 11: 529-532.

15.   Isaac Moscoso, Lazaro Claudiovino Garcia, Gilvan Oliveira Dourado, et al. Influence of Diabetes Mellitus on Immediate Results of Coronary Stent: NationalCenter for Cardiovascular Interventions (CENIC) Data Analysis Arquivos Brasileiros de Cardiologia. 2008; 86: 24-35.

16.   Aoki J., Lansky A. J., Mehran R. et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation. Febr. 10, 2009; 119(5): 687-98.

17.   Shaw R. E., Anderson. V., Brindis R.G. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) Experience: 1998-2000. J. Am. Coll. Cardiol. 2002; 39: 1104-12.

Abstract:

Background: There are no randomized trials describing outcomes of multivessel percutaneous coronary interventions (PCI) (in primary anc staged revascularization) with second generation drug eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI). We are presenting preliminary results of randomized trial (NCT01781715)

Materials and methods: Six-month outcomes of 89 consecutive patients with STEMI and multivessel coronary artery disease (CAD) (SYNTAX 18.6±7.9 points) undergoing primary PCI with zotarolimus-eluting stents (Resolute Integrity; Medtronic) were studied. We used two strategies of multivessel stenting: in primary PCI (MS primary) and multivessel stenting in staged revascularisation (MS staged) (8.5±4.2 days).

Results: We evaluated results in the overall cohort of patients, including two study groups (MS primary and MS staged). During follow-up of 6 months there was no cardiac death in overall group. We observed 3 (3.4%) non-fatal myocardial infarction (MI) due to definite stent thromboses (ST) (1.3% on the number of stents). Target vessel revascularization (TVR) was performed in 2 cases (2.2%). Major adverse cardiac event (MACE) (cardiac death, MI, TVR) was diagnosed in 4.5%.

Conclusions: Resolute Integrity stents in STEMI patients with multivessel CAD are satisfactory safely and effectively as part of the strategy of multivessel stenting in primary PCI and multivessel staged PCI (8.5±4.2 days).

References

1.     Sorjja P., Gersh B.J., Cox D.A. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur. Heart J. 2007; 28:1709-16.

2.     Jang H.L., Hun S.P., Shung Ch.Ch. Wee Hyun Park and Korea Acute Myocardial Infarction Registry Investigators. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am. J. Cardiol. 2009;104:182-89.

3.     Rasoul S., Ottervanger J.P., de Boer M.J. Predictors of 30- day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coron. Artery Dis. 2009; 20: 415-21.

4.     Webb J.G. Lowe A.M., Sanborn T.A. et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J.Am. Coll. Cardiol. 2003;42:138-86.

5.     Smith S.C., Jr., Feldman T.E., Hirshfeld J.W. Jr. et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Interventiondsummary article: a report of the AmericanCollege of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113:156-75.

6.     Ijsselmuiden A.J., Ezechiels J., Westendorp I.C., et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am.Heart.J. 2004;148:467-74.

7.     Politi L., Sgura F., Rossi R., et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart. 2010; 96:662-67.

8.     Fox K., Garcia M.A., Ardissino D. Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006;27:1341-81.

9.     Gabriel S., Stefan K., James D.A. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European Heart Journal. 2012. doi:10.1093/eurheartj/ehs215.

10.   Roe M.T., Cura F.A., Joski PS. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am. J. Cardiol. 2001; 88:170-173.

11.   Corpus R.A., House J.A., Marso S.P et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am. Heart. J. 2004; 148:493-500.

12.   Widimsky P., Holmes Jr. David R. How to treat patients with ST-elevation acute myocardial infarction and multivessel disease? European Heart Journal Advance Access published November 30, 2010. European Heart Journal doi:10.1093/eurheartj/ehq410.

13.   Politi L., Sgura F., Rossi R. et al. A randomised trial of target-vessel versus multi-vessel revascularization in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart.2010;96:662-667.

14.   Varani E., Balducelli M., Aquilina M. et al. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Catheter Cardiovasc. Interv. 2008;72:927-933.

15.   Roe M.T., Cura F.A., Joski PS. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am. J.Cardiol. 2001;88:170-173.

16.   Hannan E.L., Samadashvili Z., Walford G. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST- segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc. Interv. 2010; 3:22-31.

17.   Goldstein J.A., Demetriou D., Grines C.L. Multiple complex coronary plaques in patients with acute myocardial infarction. N. Engl. J. Med. 2000;343:915-22.

18.   Тарасов Р. С., Ганюков В. И., Шушпанников П. А. Исходы различных стратегий реваскуляризации у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении в зависимости от тяжести поражения коронарного русла по шкале «- SYNTAX». Российский кардиологический журнал. 2013; 100(2):31-32. 

Abstract:

Successful endovascular occlusion of iatrogenic arteriovenous fistula of the iliac artery and vein with tromboembolic syndrome and right ventricular insufficiency, occurred after surgical intervention on spine (mircodiscectomy of L4-L5, decompression of L5 radix). Disease spreaded under clinic of tromboembolic syndrome with formation of arteriovenous fistula and manifested like thromboembolic syndrome with right ventricular insufficiency.

References

1.     Papadoulas S., Konstantinou D., Kourea H.P, et al. Vascular injury complicating lumbar disc surgery: a systematic review. Eur. J. Vasc. Endovasc. Surg. 2002; 24: 189-195.

2.     Fruhwirth J., Koch G., Amann W., et al. Vascular complications of lumbar disc surgery. Acta Neurochir/ (Wien). 1996; 138: 912-916.

3.     Jarstfer B.S., Rich N.M. The challenge of arteriovenous fistula formation following disk surgery: a collective review. J. Trauma. 1976; 16: 726-733.

4.     Palmon S.C., Moore L.E., Lundberg J., Toung T. Venous air embolism: a review. J. Clin. Anesth. 1997; 9: 251-257.

5.     Goodkin R., Laska L.L. Vascular and visceral injuries associated with lumbar disc surgery: medicolegal implications. Surg. Neurol. 1998; 49: 358-372.

6.     Quigley T.M., Stoney R.J. Arteriovenous fistulas following lumbar laminectomy: the anatomy defined. J. Vasc. Surg. 1985; 2: 828-833.

7.     Jarstfer B.S., Rich N.M. The challenge of arteriovenous fistula formation following disk surgery: a collective review. J. Trauma. 1976; 16: 726-732.

8.     Ewah B., Calder I. Intraoperative death during lumbar discectomy. Br. J. Anaesth. 1991; 66: 721-723.

9.     Brewster D.C., May A.R., Darling R.C., et al. Variable manifestations of vascular injury during lumbar disk surgery. Arch. Surg. 1979; 114: 1026-1030.

10.   Epstein F.H., Post R.S., McDowell M. The effect of an arteriovenous fistula on renal hemodynamics and electrolyte excretion. J. Clin. Invest. 1953; 32: 233-241.

11.   McCarter D.H., Johnstone R.D., McInnes G.C., et al. Iliac arteriovenous fistula following lumbar disc surgery treated by percutaneous endoluminal stent grafting. Br. J. Surg. 1996; 83: 796-797.

12.   Burger T., Meyer F., Tautenhahn J., et al. Percutaneous treatment of rare iatrogenic arteriovenous fistulas of the lower limbs. Int. Surg. 1998; 83, 198-201.